On June 15, a memorandum of understanding was signed in St. Petersburg between JSC «Rusatom Healthcare» (part of ROSATOM) and Zeya & Associates Co., Ltd (Myanmar).
The memorandum was signed during the second day of the 26th St. Petersburg International Economic Forum by Igor Obrubov, Director General of JSC «Rusatom Healthcare» and Zeya Mon, Chairman of Zeya & Associates Co., Ltd. The signing took place in the presence of the Director General of ROSATOM Alexey Likhachov and the Ambassador of the Republic of the Union of Myanmar in the Russian Federation U Lwin Oo.
The parties have agreed to develop long-term, efficient, and mutually beneficial cooperation in the implementation of joint projects for the establishment of multifunctional facilities for processing products using ionizing radiation in Myanmar, as well as in the implementation of joint projects in the field of non-energy nuclear technologies in healthcare and the development of nuclear medicine in Myanmar. The cooperation with the partner will be overseen by the «Health Technologies» division of JSC «Rusatom Healthcare» which accumulates the expertise of ROSATOM in the field of healthcare.
«ROSATOM approaches the implementation of its healthcare tasks in the most comprehensive way possible. Our work in this area includes an isotope complex and the production of radiopharmaceuticals, the production of high-tech medical equipment, the processing of medical devices and food products with ionizing radiation, and our own medical infrastructure facilities. We are pleased to have the opportunity to develop innovative peaceful nuclear technologies together with friendly countries to increase the life expectancy and improve the quality of life for citizens» – said Igor Obrubov.
«Nuclear Medicine is vital in the health care industry. With its advanced technology and accurate diagnosis, it helps physicians to provide better treatment plans for patients, leading to a better quality of life. It has become an indispensable tool in modern medicine, and it’s importance will continue to grow in the years to come» – emphasized Zeya Mon.
For reference:
«Health Technologies» (JSC «Rusatom Healthcare») is a division that accumulates the expertise of ROSATOM in the field of healthcare. The company was created based on enterprises and institutes of ROSATOM with the aim of comprehensive development of medical technologies in Russia and abroad. The «Health Technologies» division is developing in four main areas: comprehensive solutions for medicine, production and supply of isotope products (to 50 countries worldwide), equipment for diagnosis and therapy, solutions for ionizing radiation treatment of products.
ROSATOM is among the top five largest global suppliers of raw isotope products used in the diagnosis and treatment of oncological disorders. In early 2023, construction of a new Rosatom plant for the production of medical isotopes began in Obninsk, the birthplace of the world’s first nuclear power plant. The facility will be constructed in accordance with international GMP (Good Manufacturing Practice) standards. The plant will be established on the basis of Karpov Institute of Physical Chemistry subordinated to ROSATOM and will become the leading production facility in Europe that manufactures a wide range of radiopharmaceuticals. In addition, the «Health Technologies» division is a manufacturer of medical equipment for radiation therapy and brachytherapy, implements projects for the construction of nuclear medicine centers in several regions of Russia, and is building a network of multifunctional centers for processing and sterilizing medical devices and food products in Russia and abroad.
RGK+Z&A Group is a Myanmar holding company established in 1996 as Zeya & Associates. Today RGK+Z&A Group employs over 400 qualified people in Southeast Asia and is one of the leading companies in Myanmar, having strong partnership with local and foreign organizations. RGK+Z&A Group activities are focused in Energy, Healthcare, Industry, and Environment.
